Apnex taps Boston Scientific vet as CEO

June 3, 2010 by MedCity News

Apnex Medical Inc. taps former Boston Scientific Corp. executive Charles McKhann to be its new CEO.

MedCity News logo

By Thomas Lee

Apnex Medical Inc., a St. Paul, Minn.-based start-up developing technology to treat obstructive sleep apnea, named Charles McKhann as its new CEO.

McKhann, who previously served as a global vice president of marketing for Boston Scientific Corp.’s (NYSE:BSX) cardiac rhythm management division, replaces founder and executive director Robert Atkinson. While at Johnson & Johnson (NYSE:JNJ), McKhann helped oversee the global launch of Cypher, the first drug-eluting stent.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.